The Boulder-based biotech closed on an initial $121 million Series A round in November.
2021's Most Anticipated Growth & Wealth-Building Opportunity
Join Thousands of Early Adopters Just Like You Who Want to Grow Capital and Truly Understand Cryptocurrency Together